AMST: financial statements from SEC — TradeAlmanac

AMST

Amesite Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024
Revenue	83,332	108,050	94,296	30,690	12,760	11,250
Research and development	134,192	164,853	102,888	172,098	211,867	139,658
Selling, general and administrative	549,803	578,940	547,060	428,465	804,652	633,122
Operating expenses	767,404	853,303	756,420	718,412	1m	938,594
Operating income	−684,072	−745,253	−662,124	−687,722	−1m	−927,344
Net income	−678,061	−732,548	−642,266	−663,418	−1m	−908,045
Earnings per share	−0.15	−0.16	−0.14	−0.16	−0.40	−0.34
Earnings per share, diluted	−0.15	−0.16	−0.14	−0.16	−0.40	−0.34
Weighted average shares	5m	5m	5m	4m	3m	3m
Weighted average shares, diluted	—	—	—	4m	—	—

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	640,711	1m	2m	2m	3m	619,706	1m	2m
Receivables	18,975	7,197	10,344

Cash flow

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024
Operating cash flow	—	—	−415,765	—	—	−488,263
Depreciation and amortisation	—	—	60,440

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)